Establishing an Animal Model of Secondary Osteoporosis by Using a Gonadotropin-releasing Hormone Agonist

Nur-Vaizura Mohamad1, Muhammad Afiq Amani Che Zulkepli1, Krystine May Theseira1

  • 1Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia.

Insights

Buserelin, a GnRH agonist, effectively reduces testosterone and bone microarchitecture in male rats, mimicking orchidectomy effects. Longer studies may reveal impacts on bone strength and mineral content.

Area of Science:

  • Endocrinology
  • Osteoporosis Research
  • Preclinical Animal Models

Background:

  • Orchidectomy is the standard for inducing bone loss in male osteoporosis models.
  • Gonadotropin-releasing hormone (GnRH) agonists, used in prostate cancer treatment, cause testosterone deficiency but their skeletal effects in preclinical models are less explored.

Purpose of the Study:

  • To evaluate the skeletal effects of buserelin (a GnRH agonist) in male rats.
  • To compare buserelin's skeletal effects with those of orchidectomy.

Main Methods:

  • Male Sprague-Dawley rats were divided into baseline, buserelin (25 or 75 µg/kg), and orchidectomy (or sham) groups.
  • In-vivo micro-CT scanning, blood testosterone level analysis, and femur biomechanical testing were performed over three months.

Main Results:

  • Buserelin significantly decreased testosterone levels and deteriorated bone microstructure, similar to orchidectomy.
  • Buserelin treatment affected femur biomechanical properties, while orchidectomy did not show significant changes in strength within three months.
  • Bone calcium content remained unaffected by buserelin treatment.

Conclusions:

  • Buserelin effectively induces testosterone deficiency and bone microarchitectural deterioration in rats within three months, comparable to orchidectomy.
  • Extended treatment duration might be necessary to observe significant effects on bone strength and mineral content.

Related Concept Videos

Secondary Messengers in Hormone Action01:26

Secondary Messengers in Hormone Action

Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
5.5K
Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
84.4K